Strong performance in Eastern and Western Europe
Reykjavik, Iceland 9 August 2007 - Actavis Group, the international generic pharmaceuticals company, announces its results for the second quarter ended 30 June 2007.
Highlights
Reported revenue in the second quarter increased 4.1% to EUR378.9 million (2Q 2006: EUR364.1 million) and by 7.9% to EUR761.5 million (1H 2006 EUR705.9 million) in the first half, reflecting a strong performance in Eastern and Western Europe. Underlying revenue for the quarter increased by 4.8% (2Q 2006 pro forma: EUR361.6 million) and by 7.1% for the first half (1H 2006 pro forma EUR711.1m).
View 2Q Press release (pdf)
In the coming weeks, Actavis will then formally be removed from the OMX stock exchange as requested by the Board of Directors, following the successful takeover by Novator of 99.66% of Actavis A class shares.